Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17195422rdf:typepubmed:Citationlld:pubmed
pubmed-article:17195422lifeskim:mentionsumls-concept:C0027721lld:lifeskim
pubmed-article:17195422lifeskim:mentionsumls-concept:C1552617lld:lifeskim
pubmed-article:17195422lifeskim:mentionsumls-concept:C0282443lld:lifeskim
pubmed-article:17195422pubmed:issue11lld:pubmed
pubmed-article:17195422pubmed:dateCreated2007-1-1lld:pubmed
pubmed-article:17195422pubmed:abstractTextMinimal change disease (MCD) is a histopathological lesion in the kidney that is most commonly associated with nephrotic syndrome. The majority of the cases are idiopathic. Pathogenesis is not well understood, although T-cell-related mechanisms are implicated. Massive proteinuria leads to hypoalbuminemia, salt retention, disorder of hemostasis, hyperlipidemia and increased susceptibility to infections. Renal biopsy remains the gold standard for diagnosis. MCD is highly responsive to corticosteroids. Other immunosuppressive agents such as cyclophosphamide, cyclosporin, azathioprine and mycophenolate mofetil have been used to treat cases which are resistant to steroids.lld:pubmed
pubmed-article:17195422pubmed:languageenglld:pubmed
pubmed-article:17195422pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17195422pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17195422pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17195422pubmed:statusMEDLINElld:pubmed
pubmed-article:17195422pubmed:monthNovlld:pubmed
pubmed-article:17195422pubmed:issn0038-4348lld:pubmed
pubmed-article:17195422pubmed:authorpubmed-author:SinghHarmeetHlld:pubmed
pubmed-article:17195422pubmed:authorpubmed-author:SahaTapasi...lld:pubmed
pubmed-article:17195422pubmed:issnTypePrintlld:pubmed
pubmed-article:17195422pubmed:volume99lld:pubmed
pubmed-article:17195422pubmed:ownerNLMlld:pubmed
pubmed-article:17195422pubmed:authorsCompleteYlld:pubmed
pubmed-article:17195422pubmed:pagination1264-70lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:meshHeadingpubmed-meshheading:17195422...lld:pubmed
pubmed-article:17195422pubmed:year2006lld:pubmed
pubmed-article:17195422pubmed:articleTitleMinimal change disease: a review.lld:pubmed
pubmed-article:17195422pubmed:affiliationBrody School of Medicine, East Carolina University, 2355 W. Arlington Boulevard, Greenville, North Carolina 37834, USA. sahat@ecu.edulld:pubmed
pubmed-article:17195422pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17195422pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17195422lld:pubmed